NEW YORK (GenomeWeb News) — Seoul, South Korea-based Interface Engineering will sell and service Eksigent’s NanoLC and ExpressLC high-performance liquid-chromatography systems in Korea, Eksigent said today.
 
Interface Engineering is a division of Bio-Medical Science Co., a group of Korean distribution and life-science technology companies.
 
Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.